- Home
- INTT vs IKNA Comparison
INTT vs IKNA Comparison
Compare INTT & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTT
- IKNA
- Stock Information
- Founded
- INTT 1981
- IKNA 2016
- Country
- INTT United States
- IKNA United States
- Employees
- INTT N/A
- IKNA N/A
- Industry
- INTT Semiconductors
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- INTT Technology
- IKNA Health Care
- Exchange
- INTT Nasdaq
- IKNA Nasdaq
- Market Cap
- INTT 77.3M
- IKNA 61.8M
- IPO Year
- INTT 1997
- IKNA 2021
- Fundamental
- Price
- INTT $7.46
- IKNA $1.31
- Analyst Decision
- INTT Strong Buy
- IKNA Strong Buy
- Analyst Count
- INTT 2
- IKNA 1
- Target Price
- INTT $12.00
- IKNA $4.00
- AVG Volume (30 Days)
- INTT 29.7K
- IKNA 73.1K
- Earning Date
- INTT 08-01-2025
- IKNA 08-07-2025
- Dividend Yield
- INTT N/A
- IKNA N/A
- EPS Growth
- INTT N/A
- IKNA N/A
- EPS
- INTT N/A
- IKNA N/A
- Revenue
- INTT $127,503,000.00
- IKNA N/A
- Revenue This Year
- INTT N/A
- IKNA N/A
- Revenue Next Year
- INTT $10.07
- IKNA N/A
- P/E Ratio
- INTT N/A
- IKNA N/A
- Revenue Growth
- INTT 5.19
- IKNA N/A
- 52 Week Low
- INTT $5.24
- IKNA $0.97
- 52 Week High
- INTT $11.92
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- INTT 62.53
- IKNA 48.98
- Support Level
- INTT $7.02
- IKNA $1.31
- Resistance Level
- INTT $7.72
- IKNA $1.37
- Average True Range (ATR)
- INTT 0.36
- IKNA 0.05
- MACD
- INTT 0.03
- IKNA -0.01
- Stochastic Oscillator
- INTT 74.00
- IKNA 0.00
About INTT inTest Corporation
inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.